These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3284276)

  • 1. Clinical trial of sustained-release artificial tears in keratoconjunctivitis sicca and Sjögren's syndrome.
    Lindahl G; Calissendorff B; Carle B
    Acta Ophthalmol (Copenh); 1988 Feb; 66(1):9-14. PubMed ID: 3284276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjögren's syndrome.
    Mackor AJ; van Bijsterveld OP
    Ophthalmologica; 1988; 196(4):169-74. PubMed ID: 3173983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome and tear function parameters.
    van Bijsterveld OP; Mackor AJ
    Clin Exp Rheumatol; 1989; 7(2):151-4. PubMed ID: 2736827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Punctal plugs versus artificial tears for treating primary Sjögren's syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function.
    Qiu W; Liu Z; Ao M; Li X; Wang W
    Rheumatol Int; 2013 Oct; 33(10):2543-8. PubMed ID: 23649850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca in patients with primary Sjögren's syndrome not responding to standard treatment with artificial tears].
    Ostuni P; Battista ME; Furlan A
    Reumatismo; 2005; 57(2):119-24. PubMed ID: 15983636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren's syndrome.
    Kruize AA; van Bijsterveld OP; Hené RJ; de Wilde PC; Feltkamp TE; Kater L; Bijlsma JW
    Br J Ophthalmol; 1997 Jun; 81(6):435-8. PubMed ID: 9274404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical ophthalmological tests for the diagnosis of keratoconjunctivitis sicca.
    Prause JU
    Clin Exp Rheumatol; 1989; 7(2):141-4. PubMed ID: 2736826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of the SmartPlug™ in the treatment of primary Sjogren's syndrome with keratoconjunctivitis sicca: one-year follow-up study.
    Egrilmez S; Aslan F; Karabulut G; Kabasakal Y; Yagci A
    Rheumatol Int; 2011 Dec; 31(12):1567-70. PubMed ID: 20490802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
    Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
    J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S; Kim T; Chung SH; Kim EK; Seo KY
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
    Chung JK; Kim MK; Wee WR
    Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca.
    Fox RI; Chan R; Michelson JB; Belmont JB; Michelson PE
    Arthritis Rheum; 1984 Apr; 27(4):459-61. PubMed ID: 6712760
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation and differential diagnosis of keratoconjunctivitis sicca.
    Lemp MA
    J Rheumatol Suppl; 2000 Dec; 61():11-4. PubMed ID: 11128698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity.
    Begley CG; Chalmers RL; Abetz L; Venkataraman K; Mertzanis P; Caffery BA; Snyder C; Edrington T; Nelson D; Simpson T
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4753-61. PubMed ID: 14578396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC16 expression in Sjogren's syndrome, KCS, and control subjects.
    Caffery B; Joyce E; Heynen ML; Jones L; Ritter R; Gamache DA; Senchyna M
    Mol Vis; 2008; 14():2547-55. PubMed ID: 19122828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic power of the tests for tear gland related keratoconjunctivitis sicca.
    Klaassen-Broekema N; Mackor AJ; van Bijsterveld OP
    Neth J Med; 1992 Apr; 40(3-4):113-6. PubMed ID: 1603200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome.
    Gündüz K; Ozdemir O
    Acta Ophthalmol (Copenh); 1994 Aug; 72(4):438-42. PubMed ID: 7825408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.